BehaveNet®
Clinical Capsule™

 
Join Our Mailing List

Email:

For Email Newsletters you can trust
Movies
Opinion
Facebook
Twitter

drug: methsuximide


U.S. Preparations:
  • Celontin® (Pfizer) FDA approved: for treatment of refractory absence (petit mal) epilepsy.
 


http://www.behavenet.com/capsules
Search Capsules™ | Terms of Use | Request New Term
Capsules™ Copyright © 1997-2012 BehaveNet®
Privacy | Medica Network Privacy Statement